Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Gonzalez

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinical Therapeutics|May 20, 1998
Antiplatelet therapy in atherosclerotic cardiovascular diseaseE R Gonzalez
JAMA|August 21, 1981
Methaqualone abuse implicated in injuries, deaths nationwideE R Gonzalez
The American Journal of Managed Care|January 7, 1998
The pharmacoeconomic benefits of cholesterol reductionE R Gonzalez
JAMA|June 15, 1979
From deep cold to deep sleepE R Gonzalez
JAMA|December 21, 1979
Unresolved issue: Do drinkers have less coronary heart disease?E R Gonzalez
The American Journal of Nursing|May 1, 1990
Titrating nitroglycerinE R Gonzalez
Pharmacotherapy|December 28, 1999
Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspectiveE R Gonzalez
DICP : the Annals of Pharmacotherapy|November 1, 1990
Pathophysiologic changes in the critically ill patient: risk factors for ulceration and altered drug metabolismE R Gonzalez
JAMA|June 15, 1979
Deep hypothermia for infant open heart surgery: pros and consE R Gonzalez
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Shifting paradigms of antiplatelet therapy: assessing new drugs versus old. IntroductionE R Gonzalez
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|May 20, 1998
Antiplatelet therapy in atherosclerotic cardiovascular diseaseE R Gonzalez
JAMA|August 21, 1981
Methaqualone abuse implicated in injuries, deaths nationwideE R Gonzalez
The American Journal of Managed Care|January 7, 1998
The pharmacoeconomic benefits of cholesterol reductionE R Gonzalez
JAMA|June 15, 1979
From deep cold to deep sleepE R Gonzalez
JAMA|December 21, 1979
Unresolved issue: Do drinkers have less coronary heart disease?E R Gonzalez
The American Journal of Nursing|May 1, 1990
Titrating nitroglycerinE R Gonzalez
Pharmacotherapy|December 28, 1999
Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspectiveE R Gonzalez
DICP : the Annals of Pharmacotherapy|November 1, 1990
Pathophysiologic changes in the critically ill patient: risk factors for ulceration and altered drug metabolismE R Gonzalez
JAMA|June 15, 1979
Deep hypothermia for infant open heart surgery: pros and consE R Gonzalez
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Shifting paradigms of antiplatelet therapy: assessing new drugs versus old. IntroductionE R Gonzalez
Pageof 8